Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1]
Kim WR, Brown RS Jr, Terrault NA, El-Serag H..
Burden of liver disease in the United States: summary of a workshop..
Hepatology. , 36 (2002), pp. 227-42
[2]
Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SH, et al..
Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States..
Ann Intern Med. , 137 (2002), pp. 947-54
[3]
Mitzner S, Stange J, Peszynski P, Klammt S..
Extracorporeal support of the failing liver..
Current Op Crit Care. , 8 (2002), pp. 171-7
[4]
Allen JW, Hassanein T, Bhatia SN..
Advances in bioartificial liver devices..
Hepatology. , 34 (2001), pp. 447-55
[5]
Chamuleau RA, Poyck PP, Van de Kerkhove MP..
Bioartificial liver: its pros and cons..
Ther Apher Dial. , 10 (2006), pp. 168-74
[6]
Mitzner S, Stange J, Klammt S, Peszynski P, Schmidt R, Nöldge- Schomburg G..
Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure..
J Am Soc Neprhol. , 12 (2001), pp. S75-S82
[7]
Kjaergard LL, Liu J, Als-Nielsen B, Gluud C..
Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review..
JAMA. , 289 (2003), pp. 217-22
[8]
Khuroo M, Khuroo M, Farahat K..
Molecular Adsorbent Recirculating System for acute and acute on chronic liver failure: a metaanalysis..
Liver Transpl. , 10 (2004), pp. 1099-106
[9]
Stange J, Mitzner S, Klammt S, Freytag J, Peszynski P, Loock J, et al..
Liver support by extracorporeal blood purification: a clinical observation..
Liver Transpl. , 6 (2000), pp. 603-13
[10]
Lamesch P, Jost U, Schreiter D, Scheibner L, Beier O, Fangmann J, et al..
Molecular Adsorbents Recirculating System in patients with liver failure..
Transplant Proc. , 33 (2001), pp. 3480-2
[11]
Heemann U, Treichel U, Loock J, Philipp T, Gerken G, Broelsch C, Klammt S, et al..
Albumin dialysis in cirrhosis with superimposed acute liver injury leading to severe hyperbilirubinemia..
Hepatology. , 36 (2002), pp. 949-58
[12]
Mitzner S, Stange J, Klammt S, Risler T, Erley CM, Bader BD, et al..
Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective randomized, controlled clinical trial..
Liver Transpl. , 6 (2000), pp. 277-86
[13]
Schmidt LE, Sorensen VR, Svendsen LB, Hansen BA, Larsen FS..
Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute on chronic liver failure..
Liver Transpl. , 7 (2001), pp. 1034-9
[14]
Catalina MV, Barrio J, Anaya F, Salcedo M, Rincon D, Clemente G, et al..
Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure..
Liver Int. , 23 Suppl 3 (2003), pp. 39-43
[15]
Sen S, Mookerjee RP, Cheshire LM, Davies NA, Williams R, Jalan R..
Albumin dialysis reduces portal pressure acutely in patients with severe alcoholic hepatitis..
J Hepatol. , 43 (2005), pp. 142-8
[16]
Laleman W, Wilmer A, Evenepoel P, Elst IV, Zeegers M, Zaman Z, et al..
Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure..
Crit Care. , 10 (2006), pp. R108
[17]
Stadlbauer V, Krisper P, Aigner R, Haditsch B, Jung A, Lackner C, et al..
Effect of extracorporeal liver support by MARS and Prometheus on serum cytokines in acute-on-chronic liver failure..
Crit Care. , 10 (2007), pp. R169
[18]
Jalan R, Sen S, Steiner C, Kapoor D, Alisa A, Williams R..
Extracorporeal liver support with molecular adsorbents recirculating system in patients with severe acute alcoholic hepatitis..
J Hepatol. , 38 (2003), pp. 24-31
[19]
Sen S, Davies NA, Mookerjee RP, Cheshire LM, Hodges SJ, Williams R, et al..
Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study..
Liver Transpl. , 10 (2004), pp. 1109-19
[20]
Hassanein T, Tofteng F, Brown RS, McGuire B, Lynch P, Mehta R, et al..
Randomized controlled study of extracorporeal albumin dialysis for hepatic encephalopathy in advanced cirrhosis..
Hepatology. , 46 (2007), pp. 1853-62
[21]
Doria C, Mandalá L, Scott VL, Gruttadauria S, Marino IR..
Fulminant hepatic failure bridged to liver transplantation with a molecular adsorbent recirculating system: a single-center experience..
Dig Dis Sci. , 51 (2006), pp. 47-53
[22]
Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, et al..
Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilsons disease..
Liver Transpl. , 8 (2002), pp. 962-7
[23]
Catalina MV, Núñez O, Ponferrada A, Menchen L, Matilla A, Clemente G, et al..
Toxicidad hepática tras ingesta de setas: curso clínico y nuevas perspectivas de tratamiento..
Gastroenterol Hepatol. , 26 (2003), pp. 417-20
[24]
Felldin M, Friman S, Backman L, Siewert-Delle A, Henriksson BA, Larsson B, et al..
Treatment with the molecular adsorbent recirculating system in patients with acute liver failure..
Transplant Proc. , 35 (2003), pp. 822-3
[25]
Novelli G, Rossi M, Pretagostini R, Novelli L, Poli L, Ferretti G, et al..
A 3-year experience with Molecular Adsorbent Recirculating System (MARS): our results on 63 patients with hepatic failure and color Doppler US evaluation of cerebral perfusion..
Liver Int. , 23 Suppl 3 (2003), pp. 10-5
[26]
Pares A, Cisneros L, Salmeron JM, Caballeria L, Mas A, Torras A, et al..
Extracorporeal albumin dialysis Molecular Adsorbent Recirculating System: a procedure for prolonged relief of intractable pruritus in patients with primary biliary cirrhosis..
Am J Gastroenterol. , 99 (2004), pp. 1105-10
[27]
Novelli G, Rossi M, Pretagostini R, Poli L, Peritore D, Di Nicuolo A, et al..
Use of MARS in the treatment of acute liver failure: preliminary monocentric experience..
Transplant Proc. , 33 (2001), pp. 1942-4
[28]
Liu YH, Wang Y, Yu LX, Sun LY, Feng BL, Shen ZY, et al..
Artificial liver support molecular adsorbents recirculating system therapy as a bridge to re-transplantation in two cases of long anhepatic duration..
Hepatobiliary Pancreat Dis Int. , 3 (2004), pp. 316-7
